TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1430709

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 30 micrograms fenoterol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 50 micrograms fenoterol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 100 micrograms fenoterol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 200 micrograms fenoterol
Number of subjects: 6
Study: 3996846

Group type: EXPERIMENTAL
Intervention: Glucagon (3 to 22 micrograms/kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Glucagon (7 micrograms/kg)
Number of subjects: 18
Study: 30206423

Group type: EXPERIMENTAL
Intervention: Robotic therapy (RT) using the Armeo Power
Number of subjects: 34

Group type: COMPARATOR
Intervention: Occupational therapy (OT)
Number of subjects: 34
Study: 29513075

Group type: EXPERIMENTAL
Intervention: Health food messages with positive emotional valence, attractiveness, authoritative sender, longer arguments, and direct messages.
Number of subjects: 1496

Group type: EXPERIMENTAL
Intervention: Health food messages with external evidence.
Number of subjects: 1496

Group type: EXPERIMENTAL
Intervention: Health food messages with hashtags.
Number of subjects: 1496

Group type: EXPERIMENTAL
Intervention: Health food messages containing only positive or negative emotions or direct messages without support information.
Number of subjects: 1496
Study: 26758852

Group type: EXPERIMENTAL
Intervention: High activity group (Tegner≥5, n=115)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Low activity group (Tegner≤4, n=885)
Number of subjects: 1000
Study: 25353633

Group type: EXPERIMENTAL
Intervention: Delayed disc surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-and-see (control)
Number of subjects: 0
Study: 22409590

Group type: EXPERIMENTAL
Intervention: 40 mg S-equol/day
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 20 mg S-equol/day
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 10 mg S-equol/day
Number of subjects: 102

Group type: COMPARATOR
Intervention: Soy isoflavones
Number of subjects: 102
Study: 19825901

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18312063

Group type: EXPERIMENTAL
Intervention: Culturally adapted HIV risk reduction curriculum
Number of subjects: 380

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 380
Study: 16282844

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (50 mg for days 1-3; 100 mg for days 4-10)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 12161769

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (Viagra®)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 546
Study: 10450540

Group type: EXPERIMENTAL
Intervention: Mud packs combined with antidepressant treatment (trazodone)
Number of subjects: 0
Study: 7759275

Group type: EXPERIMENTAL
Intervention: Exercise rehabilitation (ER) and an 8-week stress management (SM) program (ER + SM)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Exercise rehabilitation (ER) only
Number of subjects: 45
Study: 2179067

Group type: EXPERIMENTAL
Intervention: Acyclovir (400 mg bid)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 396686

Group type: EXPERIMENTAL
Intervention: Intravenous methyl prednisolone administered immediately before bypass
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 31
Study: 31411516

Group type: EXPERIMENTAL
Intervention: Web platform access (including resources, forum and virtual interactions) for three months
Number of subjects: 28

Group type: COMPARATOR
Intervention: Access to resources only (control group)
Number of subjects: 28
Study: 31255240

Group type: EXPERIMENTAL
Intervention: Pharmacist-led dressing reconciliations in the intervention group.
Number of subjects: 39

Group type: COMPARATOR
Intervention: Classic patient care in the control group.
Number of subjects: 39
Study: 28435033

Group type: EXPERIMENTAL
Intervention: Solifenacin
Number of subjects: 3011

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3011
Study: 26519710

Group type: EXPERIMENTAL
Intervention: 20% human albumin (5 mL/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.9% saline (5 mL/kg)
Number of subjects: 50
Study: 23506005

Group type: EXPERIMENTAL
Intervention: New toothbrush with dentifrice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Old toothbrush with dentifrice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New toothbrush without dentifrice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Old toothbrush without dentifrice
Number of subjects: 0
Study: 22034115

Group type: EXPERIMENTAL
Intervention: Varus contralateral knees
Number of subjects: 78

Group type: COMPARATOR
Intervention: Neutral contralateral knees
Number of subjects: 78

Group type: COMPARATOR
Intervention: Valgus contralateral knees
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Overall contralateral knees followed longitudinally
Number of subjects: 78
Study: 18478814

Group type: EXPERIMENTAL
Intervention: 4% intracuff lidocaine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 38
Study: 30311485

Group type: EXPERIMENTAL
Intervention: Cross 1×4
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cross 1×7
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cross 2×4
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cross 1×6
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cross 2×3
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cross 2×5
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cross 2×6
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cross 2×7
Number of subjects: 5
Study: 12920685

Group type: EXPERIMENTAL
Intervention: Excluder endograft
Number of subjects: 100
Study: 10699609

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (10-hertz square waves of 1-ms pulse duration, vaginal electrode for women, anal or surface electrode for men) for 15 minutes twice daily for 4 weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 68
Study: 9112351

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 412

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 412
Study: 1547684

Group type: EXPERIMENTAL
Intervention: Glyburide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3157577

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: atenolol and hydralazine
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: methyl dopa
Number of subjects: 43
Study: 29872225

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 61

Group type: COMPARATOR
Intervention: SitLess
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Sit
Number of subjects: 61
Study: 27404026

Group type: EXPERIMENTAL
Intervention: CE/BZA 0.45/20 mg
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: CE/BZA 0.625/20 mg
Number of subjects: 664

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 664
Study: 24560760

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (39Gy/13 fractions in 2.6 weeks)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional radiotherapy (54Gy/30 fractions in 6 weeks)
Number of subjects: 71
Study: 22188269

Group type: EXPERIMENTAL
Intervention: Age-related, height-based (ARHB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nose-ear-mid-umbilicus (NEMU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nose-ear-xiphoid (NEX)
Number of subjects: 0
Study: 20537851

Group type: EXPERIMENTAL
Intervention: Nebulized morphine administered every 30 minutes until the second hour, then every 4 hours for 48 hours
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thoracic epidural analgesia with a mixture of 0.125% bupivacaine and 0.115% fentanyl continuously infused at 7 ml/h for 48 hours
Number of subjects: 40
Study: 18504089

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Analgesic Imagery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Condition
Number of subjects: 40
Study: 15503293

Group type: EXPERIMENTAL
Intervention: 6-thioguanine (TG) at a targeted dose of 50 mg/m²/day during maintenance therapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 6-thioguanine (TG)
Number of subjects: 12
Study: 12029227

Group type: EXPERIMENTAL
Intervention: Transperitoneal laparoscopic retropubic urethropexy using non absorbable sutures
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prolene meshes fixed with tackers or staplers
Number of subjects: 60
Study: 10581656

Group type: EXPERIMENTAL
Intervention: Vitalograph bellows spirometer
Number of subjects: 6

Group type: COMPARATOR
Intervention: MicroMedical turbine spirometer
Number of subjects: 6
Study: 8934478

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 39

Group type: COMPARATOR
Intervention: External fixation (with or without limited internal fixation)
Number of subjects: 39
Study: 1877441

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Combined therapy with metoprolol and nifedipine
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 101
Study: 6193771

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 245

Group type: COMPARATOR
Intervention: Observation only
Number of subjects: 245
Study: 31994307

Group type: EXPERIMENTAL
Intervention: THD® Anopress manometry
Number of subjects: 60

Group type: COMPARATOR
Intervention: High-resolution water-perfused manometry (WPM)
Number of subjects: 60
Study: 31535388

Group type: EXPERIMENTAL
Intervention: TMS at 110% RMT applied at the negative peak of the μ-rhythm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TMS at 110% RMT applied at the positive peak of the μ-rhythm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative peak-triggered 90% RMT TMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 0
Study: 28431480

Group type: EXPERIMENTAL
Intervention: Doxorubicin-ifosfamide chemotherapy
Number of subjects: 310

Group type: COMPARATOR
Intervention: Single-agent doxorubicin
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (doxorubicin-ifosfamide)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Doxorubicin-ifosfamide
Number of subjects: 310
Study: 26547059

Group type: EXPERIMENTAL
Intervention: Likelihood text-messages in Study 1
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Likelihood text-messages in Study 2
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Severity text-messages in Study 2
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Presence of a picture with smokers' diseased lungs in Study 2
Number of subjects: 797
Study: 25482242

Group type: EXPERIMENTAL
Intervention: NCC plus pill organizer
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: NCC plus medication-dispensing machine
Number of subjects: 414

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 414
Study: 22514211

Group type: EXPERIMENTAL
Intervention: Fish oil (3 g/day for 4 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Olive oil (3 g/day for 4 weeks)
Number of subjects: 29
Study: 19460770

Group type: EXPERIMENTAL
Intervention: G-CSF (10 microg/kg/day) injection for 3 days after PCI in the AMI-G-CSF group.
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: G-CSF (10 microg/kg/day) injection for 3 days after PCI in the OMI-G-CSF group.
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no G-CSF treatment) in the AMI-control group.
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no G-CSF treatment) in the OMI-control group.
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no G-CSF treatment) in the healthy-control group.
Number of subjects: 76
Study: 17526858

Group type: EXPERIMENTAL
Intervention: Enteric-coated mycophenolate (360 mg twice daily)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (500 mg twice daily)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 7
Study: 15577621

Group type: EXPERIMENTAL
Intervention: Interleukin-2 therapy (9 x 10(6) IU/day for 4-5 days)
Number of subjects: 32
Study: 11669254

Group type: EXPERIMENTAL
Intervention: Bio-Oss with Bio-Gide (M+)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Bio-Oss without Bio-Gide (M-)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control implants in adjacent native bone
Number of subjects: 29
Study: 9618617

Group type: EXPERIMENTAL
Intervention: 1 injection of tetanus toxoid
Number of subjects: 41571

Group type: EXPERIMENTAL
Intervention: 2 injections of tetanus toxoid
Number of subjects: 41571

Group type: COMPARATOR
Intervention: Unimmunized mothers
Number of subjects: 41571
Study: 7999529

Group type: EXPERIMENTAL
Intervention: Oral magnesium supplementation in ischaemic heart disease patients
Number of subjects: 712

Group type: COMPARATOR
Intervention: High-risk controls (HR)
Number of subjects: 712

Group type: COMPARATOR
Intervention: Low-risk controls (LR)
Number of subjects: 712
Study: 3133712

Group type: COMPARATOR
Intervention: Amitriptyline (75 mg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Mianserin (60 mg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Trazodone (150 mg)
Number of subjects: 75
Study: 30335073

Group type: EXPERIMENTAL
Intervention: Phenazepam (1 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 28830517

Group type: EXPERIMENTAL
Intervention: Ibrutinib plus rituximab (IR)
Number of subjects: 754

Group type: COMPARATOR
Intervention: Fludarabine, cyclophosphamide and rituximab (FCR)
Number of subjects: 754
Study: 25387888

Group type: EXPERIMENTAL
Intervention: Prasugrel (10 mg once daily for 15 days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 23157654

Group type: EXPERIMENTAL
Intervention: adalimumab
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: etanercept
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: infliximab
Number of subjects: 72
Study: 22014970

Group type: EXPERIMENTAL
Intervention: Wound infiltration with 0.5% bupivacaine and i.m. 75 mg diclofenac (group BD)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Wound infiltration with saline and i.m. saline (group P)
Number of subjects: 96
Study: 19164830

Group type: EXPERIMENTAL
Intervention: Oral quercetin (250 mg, 4x/day; 1,000 mg/day total)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Quercetin-free supplements
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Oral quercetin
Number of subjects: 63
Study: 16862243

Group type: EXPERIMENTAL
Intervention: Tryptophan (3 g/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12506181

Group type: EXPERIMENTAL
Intervention: Fish oil capsules
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11463999

Group type: EXPERIMENTAL
Intervention: Intensified dietary counselling, ready-made liquid nutritional supplements free of charge, regular follow-ups
Number of subjects: 42

Group type: COMPARATOR
Intervention: Simple dietary support (one session of individual dietary counselling, no supplements, no follow-ups)
Number of subjects: 42
Study: 9923569

Group type: EXPERIMENTAL
Intervention: Mibefradil (50 mg)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 8067223

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 10
Study: 3057512

Group type: EXPERIMENTAL
Intervention: 100 mg tramadol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 50 mg tramadol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1,000 mg metamizole
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 500 mg metamizole
Number of subjects: 10
Study: 31216547

Group type: EXPERIMENTAL
Intervention: HULA (weighted hula-hooping for 6 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: WALK (walking for 6 weeks)
Number of subjects: 55
Study: 28072707

Group type: EXPERIMENTAL
Intervention: Group-based strength training (physical exercise group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Individual ergonomic training and education (reference group)
Number of subjects: 66
Study: 25925999

Group type: EXPERIMENTAL
Intervention: Midazolam + Tramadol (M + T)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Midazolam + Saline (M + S)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (C) - no sedation
Number of subjects: 87
Study: 22640573

Group type: EXPERIMENTAL
Intervention: Balance-focused virtual-reality games
Number of subjects: 36

Group type: COMPARATOR
Intervention: Therapeutic balance exercises
Number of subjects: 36
Study: 21613037

Group type: EXPERIMENTAL
Intervention: 980 nm diode laser at 1.5 W/100 Hz
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 980 nm diode laser at 1.5 W/continuous wave (CW)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 980 nm diode laser at 3.0 W/100 Hz
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 980 nm diode laser at 3.0 W/CW
Number of subjects: 50

Group type: COMPARATOR
Intervention: No irradiation (Control)
Number of subjects: 50
Study: 18760803

Group type: COMPARATOR
Intervention: NCPAP+6
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: HFNC at 6 L/minute
Number of subjects: 15
Study: 16946694

Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg/day
Number of subjects: 367

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Aripiprazole 5 mg/day
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Aripiprazole 2 mg/day
Number of subjects: 367
Study: 15770435

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering medication adherence
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Older participants, no formal educational qualifications, personal history of cardiovascular disease, lower total cholesterol level, greater difference between untreated cholesterol levels and current cholesterol levels
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Lower perceived risk of raised cholesterol, perceiving greater control over FH, perceiving genes and cholesterol to be important determinants of a heart attack
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Having personal history of cardiovascular disease, having no formal qualifications, perceiving genes to be important determinants of a heart attack
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Intervention strategies aimed at helping patients to establish routines for medication taking
Number of subjects: 336
Study: 11743151

Group type: EXPERIMENTAL
Intervention: Individualised structured feedback report concerning evaluations of care provided by their own patients.
Number of subjects: 3691
Study: 9032500

Group type: EXPERIMENTAL
Intervention: Dirithromycin, 500 mg orally once daily for five consecutive days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Erythromycin base, 1000 mg orally four times daily for seven days
Number of subjects: 20
Study: 8389738

Group type: EXPERIMENTAL
Intervention: Lisinopril (L) 10, 20, or 40 mg per day
Number of subjects: 91

Group type: COMPARATOR
Intervention: Captopril (C) 25, 50, or 100 mg b.i.d.
Number of subjects: 91
Study: 31809200

Group type: EXPERIMENTAL
Intervention: Emergency contraception (EC) awareness and knowledge assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attitude towards emergency contraception (EC)
Number of subjects: 0
Study: 31327650

Group type: EXPERIMENTAL
Intervention: 5-min CWI at 8 °C (CWI-5)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 2.5-min CWI at 8 °C (CWI-2.5)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Passive rest
Number of subjects: 10
Study: 28755622

Group type: EXPERIMENTAL
Intervention: Lithium-based treatment
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Quetiapine-based treatment
Number of subjects: 482

Group type: COMPARATOR
Intervention: Randomized treatment (Lithium or Quetiapine)
Number of subjects: 482
Study: 26381346

Group type: EXPERIMENTAL
Intervention: Computer-based learning with voice-activated manikins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Instructor-led basic life support
Number of subjects: 0
Study: 23163412

Group type: EXPERIMENTAL
Intervention: Family obligation values
Number of subjects: 48
Study: 21672502

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 627
Study: 18806703

Group type: EXPERIMENTAL
Intervention: VSL[sharp]3 probiotic mixture
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 17409909

Group type: EXPERIMENTAL
Intervention: Pemetrexed plus cisplatin (500 mg/m pemetrexed + 75 mg/m cisplatin)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Pemetrexed alone (500 mg/m)
Number of subjects: 187
Study: 14657066

Group type: EXPERIMENTAL
Intervention: Echinacea
Number of subjects: 407
Study: 11014759

Group type: EXPERIMENTAL
Intervention: False alarms present
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Interactive support tool
Number of subjects: 69

Group type: COMPARATOR
Intervention: Non-interactive support tool
Number of subjects: 69
Study: 8784310

Group type: EXPERIMENTAL
Intervention: Billroth I procedure
Number of subjects: 62

Group type: COMPARATOR
Intervention: Billroth II procedure
Number of subjects: 62
Study: 1622858

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 355

Group type: COMPARATOR
Intervention: Immediate surgery without neoadjuvant chemotherapy
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Local resection
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Amputation
Number of subjects: 355
Study: 6147454

Group type: EXPERIMENTAL
Intervention: H2-receptor antagonist ranitidine (150 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: H1-receptor antagonist terfenadine (60 mg)
Number of subjects: 5
Study: 31364286

Group type: EXPERIMENTAL
Intervention: Next-generation sequencing (NGS)
Number of subjects: 441

Group type: COMPARATOR
Intervention: Sanger sequencing
Number of subjects: 441

Group type: COMPARATOR
Intervention: Sanger sequencing followed by NGS
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Overall detection rate
Number of subjects: 441
Study: 30397706

Group type: EXPERIMENTAL
Intervention: AuraGain
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: i-Gel
Number of subjects: 114

Group type: COMPARATOR
Intervention: ETT
Number of subjects: 114